Methylergonovine 0.2 MG tablet 12S
Ended Awarded Last action
- Contract number
- SPE2DR26FJB7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,334
Award facts
- Contract value 100% obligated
- $1,334.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Methylergonovine 0.2 mg tablets (12-pack units) with a ceiling value of $1,334.15. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its DLA Troop Support Medical contract vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical devices, including specialty medications, generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. Methylergonovine is an ergot alkaloid medication primarily used in obstetric settings to prevent or treat postpartum hemorrhage, aligning with AmerisourceBergen's role as a key pharmaceutical vendor for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FJB7N?
SPE2DR26FJB7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FJB7N worth?
The government has obligated $1,334 on SPE2DR26FJB7N.
Is contract SPE2DR26FJB7N an order under another contract?
Yes. SPE2DR26FJB7N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB7N competed?
The extent of competition for SPE2DR26FJB7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award